Literature DB >> 17582041

A quality control programme for acute myocardial infarction management in out-of-hospital critical care medicine.

Francois-Xavier Duchateau1, M L Devaud, A Burnod, J Mantz, A Ricard-Hibon.   

Abstract

This study, conducted over two time periods, aimed to evaluate the effectiveness of the diffusion of data, implementation of correctives measures and updated protocols in reducing time to reperfusion in acute myocardial infarction (AMI) management in the out-of-hospital setting. Mean (SD) time to hospital admission and to arterial puncture improved (58 (13) vs 67 (18) min, p = 0.03; and 82 (16) vs 95 (29) min, p = 0.02). The study, performed according to quality control programme methodology, showed that the chronology of AMI management could be improved by appropriate interventions and monitoring of intervention times.

Entities:  

Mesh：

Year:  2007        PMID： 17582041      PMCID： PMC2658396          DOI： 10.1136/emj.2007.046888

Source DB:  PubMed          Journal:  Emerg Med J        ISSN： 1472-0205            Impact factor:   2.740


  9 in total

1.  Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.

Authors: 
Journal:  Lancet       Date:  2006-02-18       Impact factor: 79.321

2.  Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry.

Authors:  P G Steg; J-P Cambou; P Goldstein; E Durand; P Sauval; Z Kadri; D Blanchard; J-M Lablanche; P Guéret; Y Cottin; J-M Juliard; G Hanania; L Vaur; N Danchin
Journal:  Heart       Date:  2006-08-16       Impact factor: 5.994

Review 3.  Management of prehospital thrombolytic therapy in ST-segment elevation acute coronary syndrome (<12 hours).

Authors:  P Goldstein; E Wiel
Journal:  Minerva Anestesiol       Date:  2005-06       Impact factor: 3.051

4.  Strategies for reducing the door-to-balloon time in acute myocardial infarction.

Authors:  Elizabeth H Bradley; Jeph Herrin; Yongfei Wang; Barbara A Barton; Tashonna R Webster; Jennifer A Mattera; Sarah A Roumanis; Jeptha P Curtis; Brahmajee K Nallamothu; David J Magid; Robert L McNamara; Janet Parkosewich; Jerod M Loeb; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

5.  Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.

Authors:  C P Cannon; C M Gibson; C T Lambrew; D A Shoultz; D Levy; W J French; J M Gore; W D Weaver; W J Rogers; A J Tiefenbrunn
Journal:  JAMA       Date:  2000-06-14       Impact factor: 56.272

6.  Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.

Authors:  Duane S Pinto; Ajay J Kirtane; Brahmajee K Nallamothu; Sabina A Murphy; David J Cohen; Roger J Laham; Donald E Cutlip; Eric R Bates; Paul D Frederick; Dave P Miller; Joseph P Carrozza; Elliott M Antman; Christopher P Cannon; C Michael Gibson
Journal:  Circulation       Date:  2006-10-30       Impact factor: 29.690

7.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.

Authors:  E Boersma; A C Maas; J W Deckers; M L Simoons
Journal:  Lancet       Date:  1996-09-21       Impact factor: 79.321

Review 8.  Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2006-02-18       Impact factor: 79.321

9.  Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

Authors:  Frans Van de Werf; Diego Ardissino; Amadeo Betriu; Dennis V Cokkinos; Erling Falk; Keith A A Fox; Desmond Julian; Maria Lengyel; Franz-Josef Neumann; Witold Ruzyllo; Christian Thygesen; S Richard Underwood; Alec Vahanian; Freek W A Verheugt; William Wijns
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.